D. Eric Mendelson's most recent trade in National Health Investors, Inc. was a trade of 394 Common Stock done at an average price of $76.0 . Disclosure was reported to the exchange on May 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
National Health Investors,... | D. Eric Mendelson | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.04 per share. | 05 May 2025 | 394 | 96,133 (0%) | 0% | 76.0 | 29,960 | Common Stock |
National Health Investors,... | D. Eric Mendelson | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) 2025 | |
National Health Investors,... | D. Eric Mendelson | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) 2025 | |
National Health Investors,... | D. Eric Mendelson | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) 2025 | |
National Health Investors,... | D. Eric Mendelson | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 8,000 | 96,527 (0%) | 0% | 0 | Common Stock | |
National Health Investors,... | D. Eric Mendelson | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.96 per share. | 23 Feb 2025 | 267 | 88,527 (0%) | 0% | 69.0 | 18,412 | Common Stock |